Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
|
The following article is a part of conference coverage from CHEST 2021, being held virtually from October 17 to October 20, 2021. The team at Pulmonology Advisor will be reporting on the latest news and research conducted by leading experts in the field. Check back for more from CHEST 2021. |
A home-based management program for chronic obstructive pulmonary disease (COPD) has the potential to significantly reduce hospitalizations and improve quality of life for patients. This was demonstrated through findings presented at the CHEST 2021 Annual Meeting, held virtually October 17 to 20.
Researchers evaluated the effect of a multifaceted, ongoing home-based COPD management program on 9091 patients from June 2019 to May 2021, with the hospital admission rate as the primary outcome. All study participants had COPD with a history of hospitalizations for respiratory failure and were on noninvasive ventilatory therapy.
The home-based management program used goal-based, assessment-driven COPD software administered by a respiratory therapist via in-home or telemedicine visits. Patients received monthly visits and follow up calls in accordance with their risk profile and care plan. The 9091 patients received more than 278,000 assessments, yielding more than 10 million data points.
Patient self-reported hospital admissions during the study period were measured at 12 months and compared with admission history for the prior 12 months. Researchers found that patients in the program experienced 60% fewer admissions over prior history.
Researchers concluded that this type of home-based, software-driven COPD management program led by respiratory therapists can significantly affect COPD admissions and quality of care. “This demonstrates the opportunity for greater collaboration between physicians, discharge programs, and home medical equipment providers to significantly improve COPD management,” they noted.
Disclosures: Authors declared an owner/founder relationship with the company whose home-based management system was studied. Please refer to original abstract for full details.
Reference
Gantt Z, Seifer F. Home-based COPD program reduces admissions by 55% with patients on noninvasive ventilator therapy. Presented at: CHEST 2021; October 17-20, 2021; Orlando, FL/Virtual. Abstract A2365.
